A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization

Upon withdrawal of propacetamol, an injectable formulation of the paracetamol prodrug, in Europe due to safety concerns, South Korea’s regulatory body requested a post-marketing surveillance study exploring its safety profile. We characterized regional disparities in adverse events (AE) associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Han Eol, Bea, Sungho, Yoon, Dongwon, Jung, Juhong, Park, Seung-Mok, Jeon, Juhee, Ye, Young-Min, Lee, Jae-Hyun, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747950/
https://www.ncbi.nlm.nih.gov/pubmed/36513759
http://dx.doi.org/10.1038/s41598-022-26211-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747950/
https://www.ncbi.nlm.nih.gov/pubmed/36513759
http://dx.doi.org/10.1038/s41598-022-26211-0

Ejemplares similares